Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor.

导出 OA

翻译打印收藏纠错

作者： Sameek,Singh ^[1] ; Caitlin R M,Oyagawa ^[2] ; Christa,Macdonald ^[2] ; Natasha L,Grimsey ^[2] ; Michelle,Glass ^[2] ; Andrea J,Vernall ^[1]

作者单位： School of Pharmacy, University of Otago, Dunedin, New Zealand. ^[1] Department of Pharmacology and Clinical Pharmacology, and Centre for Brain Research, School of Medical Sciences, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand. ^[2]

DOI 10.1021/acsmedchemlett.8b00597

PMID 30783505

发布时间 2020-09-29

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览15

ACS medicinal chemistry letters

2019年10卷2期

209-214页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor.

ACS medicinal chemistry letters

相似文献

ACS medicinal chemistry letters

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

Chromenopyrazole-based High Affinity, Selective Fluorescent Ligands for Cannabinoid Type 2 Receptor.

ACS medicinal chemistry letters

相似文献

ACS medicinal chemistry letters

相关期刊

检索历史清除